Under the partnership, Plug and Play will co-develop an Innovation Strategy Roadmap to accelerate Brave Connective's multi-brand growth and regional expansion. The engagement will also allow Brave ...
Pivot to Growth Strategy Progress: Teva is accelerating its Pivot to Growth strategy, focusing on transforming into a leading innovative biopharmaceutical company through late-stage innovative ...
Based on the topline results from HERIZON-GEA-01, Jazz plans to submit a supplemental Biologics License Application in 1H-2026 for zanidatamab in the U.S. as first-line treatment for HER2+ locally ...
Esperion will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2025, at 2:15 p.m. PT (5:15 p.m. ET).
TEV-‘408 is an investigational human monoclonal antibody designed to inhibit interleukin-15 (IL-15), a cytokine involved in immune-mediated pathways. TEV-‘408 has a high affinity and potency (in vitro ...
Deliver on 2026 OJEMDA net product revenue guidance, with a focus on increasing persistency and driving new patient starts to support continued OJEMDA adoption as standard of care (SOC) in 2L ...
Phase 1/2a study with lead Radio-DARPin MP0712 initiated; first patient dosing expected Q1 2026, initial data anticipated in 2026; Full imaging and dosimetry data from MP0712 comp ...
Future-proof their business with a unified open standard to power additional commerce actions ...
• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at month-24 post-treatment Patient 1 ...
在天災肆虐、內戰持續的風雨飄搖中，由軍方掌控的緬甸政府於去（2025）年底舉行了 2021 年政變後的首次大選，並將在本（1）月 25 日舉行第二階段投票，然而儘管軍方大肆宣傳選舉有助讓緬甸邁向新時代，第一階段的投票率低靡暴露出選民信心低落的現實。
氣象署表示，大陸冷氣團預計明（12）日白天起減弱，白天溫度回升，不過，未來一週將有 2 波東北季風接力影響，各地白天高溫都可在攝氏 20 度以上，低溫約 13 到 14 度，部分區域受輻射冷卻影響可能更低。
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback